Annual Retained Earnings
-$217.48 M
-$37.98 M-21.16%
31 December 2023
Summary:
Cellectar Biosciences annual retained earnings is currently -$217.48 million, with the most recent change of -$37.98 million (-21.16%) on 31 December 2023. During the last 3 years, it has fallen by -$90.71 million (-71.55%). CLRB annual retained earnings is now -1312.35% below its all-time high of -$15.40 million, reached on 31 December 2005.CLRB Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$244.99 M
-$14.66 M-6.37%
30 September 2024
Summary:
Cellectar Biosciences quarterly retained earnings is currently -$244.99 million, with the most recent change of -$14.66 million (-6.37%) on 30 September 2024. Over the past year, it has dropped by -$34.95 million (-16.64%). CLRB quarterly retained earnings is now -189371.85% below its all-time high of -$129.30 thousand, reached on 31 March 2005.CLRB Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLRB Retained Earnings Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -21.2% | -16.6% |
3 y3 years | -71.5% | -69.0% |
5 y5 years | -122.9% | -126.2% |
CLRB Retained Earnings High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -71.5% | at low | -69.0% | at low |
5 y | 5 years | -122.9% | at low | -126.2% | at low |
alltime | all time | -1312.3% | at low | <-9999.0% | at low |
Cellectar Biosciences Retained Earnings History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | -$244.99 M(+6.4%) |
June 2024 | - | -$230.32 M(-3.7%) |
Mar 2024 | - | -$239.06 M(+17.9%) |
Dec 2023 | -$217.48 M(+21.2%) | -$202.76 M(-3.5%) |
Sept 2023 | - | -$210.03 M(+7.0%) |
June 2023 | - | -$196.30 M(+4.4%) |
Mar 2023 | - | -$188.08 M(+17.6%) |
Dec 2022 | -$179.50 M(+19.0%) | -$159.99 M(-7.1%) |
Sept 2022 | - | -$172.28 M(+4.7%) |
June 2022 | - | -$164.47 M(+4.7%) |
Mar 2022 | - | -$157.04 M(+4.1%) |
Dec 2021 | -$150.90 M(+19.0%) | -$150.90 M(+4.1%) |
Sept 2021 | - | -$144.98 M(+4.2%) |
June 2021 | - | -$139.16 M(+4.5%) |
Mar 2021 | - | -$133.13 M(+5.0%) |
Dec 2020 | -$126.78 M(+13.5%) | -$126.78 M(+2.9%) |
Sept 2020 | - | -$123.16 M(+3.3%) |
June 2020 | - | -$119.25 M(+3.1%) |
Mar 2020 | - | -$115.64 M(+3.5%) |
Dec 2019 | -$111.68 M(+14.4%) | -$111.68 M(+3.1%) |
Sept 2019 | - | -$108.30 M(+3.7%) |
June 2019 | - | -$104.40 M(+3.1%) |
Mar 2019 | - | -$101.21 M(+3.7%) |
Dec 2018 | -$97.59 M(+15.7%) | -$97.59 M(+4.1%) |
Sept 2018 | - | -$93.76 M(+3.3%) |
June 2018 | - | -$90.75 M(+3.3%) |
Mar 2018 | - | -$87.83 M(+4.1%) |
Dec 2017 | -$84.35 M(+19.2%) | -$84.35 M(+5.1%) |
Sept 2017 | - | -$80.27 M(+4.5%) |
June 2017 | - | -$76.80 M(+4.2%) |
Mar 2017 | - | -$73.68 M(+4.1%) |
Dec 2016 | -$70.79 M(+9.6%) | -$70.79 M(+3.8%) |
Sept 2016 | - | -$68.20 M(+3.5%) |
June 2016 | - | -$65.92 M(+3.3%) |
Mar 2016 | - | -$63.78 M(-1.3%) |
Dec 2015 | -$64.61 M(+9.3%) | -$64.61 M(-1.5%) |
Sept 2015 | - | -$65.56 M(+2.9%) |
June 2015 | - | -$63.70 M(+3.7%) |
Mar 2015 | - | -$61.41 M(+3.9%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2014 | -$59.11 M(+15.8%) | -$59.11 M(+4.4%) |
Sept 2014 | - | -$56.59 M(+0.9%) |
June 2014 | - | -$56.09 M(+3.9%) |
Mar 2014 | - | -$54.00 M(+5.8%) |
Dec 2013 | -$51.06 M(+26.8%) | -$51.06 M(+8.4%) |
Sept 2013 | - | -$47.11 M(+2.9%) |
June 2013 | - | -$45.80 M(+4.7%) |
Mar 2013 | - | -$43.73 M(+8.6%) |
Dec 2012 | -$40.28 M(+27.9%) | -$40.28 M(+5.7%) |
Sept 2012 | - | -$38.12 M(+5.7%) |
June 2012 | - | -$36.07 M(+6.6%) |
Mar 2012 | - | -$33.84 M(+7.5%) |
Dec 2011 | -$31.48 M(+30.9%) | -$31.48 M(+6.7%) |
Sept 2011 | - | -$29.51 M(+6.9%) |
June 2011 | - | -$27.61 M(-63.2%) |
Mar 2011 | - | -$74.99 M(+211.9%) |
Dec 2010 | -$24.05 M(-68.4%) | -$24.05 M(-67.2%) |
Sept 2010 | - | -$73.38 M(+1.7%) |
June 2010 | - | -$72.15 M(+2.0%) |
Mar 2010 | - | -$70.72 M(-7.0%) |
Dec 2009 | -$76.07 M(+27.4%) | -$76.07 M(+20.3%) |
Sept 2009 | - | -$63.21 M(+4.5%) |
June 2009 | - | -$60.47 M(+8.7%) |
Mar 2009 | - | -$55.61 M(-6.8%) |
Dec 2008 | -$59.69 M(+38.0%) | -$59.69 M(+3.7%) |
Sept 2008 | - | -$57.55 M(+4.6%) |
June 2008 | - | -$55.02 M(+9.3%) |
Mar 2008 | - | -$50.34 M(+16.4%) |
Dec 2007 | -$43.24 M(+82.6%) | -$43.24 M(+17.8%) |
Sept 2007 | - | -$36.70 M(+21.2%) |
June 2007 | - | -$30.29 M(+16.2%) |
Mar 2007 | - | -$26.07 M(+10.1%) |
Dec 2006 | -$23.68 M(+53.8%) | -$23.68 M(+12.7%) |
Sept 2006 | - | -$21.01 M(+15.4%) |
June 2006 | - | -$18.21 M(+8.7%) |
Mar 2006 | - | -$16.75 M(+8.8%) |
Dec 2005 | -$15.40 M | -$15.40 M(+4.8%) |
Sept 2005 | - | -$14.69 M(+7.0%) |
June 2005 | - | -$13.74 M(>+9900.0%) |
Mar 2005 | - | -$129.30 K |
FAQ
- What is Cellectar Biosciences annual retained earnings?
- What is the all time high annual retained earnings for Cellectar Biosciences?
- What is Cellectar Biosciences annual retained earnings year-on-year change?
- What is Cellectar Biosciences quarterly retained earnings?
- What is the all time high quarterly retained earnings for Cellectar Biosciences?
- What is Cellectar Biosciences quarterly retained earnings year-on-year change?
What is Cellectar Biosciences annual retained earnings?
The current annual retained earnings of CLRB is -$217.48 M
What is the all time high annual retained earnings for Cellectar Biosciences?
Cellectar Biosciences all-time high annual retained earnings is -$15.40 M
What is Cellectar Biosciences annual retained earnings year-on-year change?
Over the past year, CLRB annual retained earnings has changed by -$37.98 M (-21.16%)
What is Cellectar Biosciences quarterly retained earnings?
The current quarterly retained earnings of CLRB is -$244.99 M
What is the all time high quarterly retained earnings for Cellectar Biosciences?
Cellectar Biosciences all-time high quarterly retained earnings is -$129.30 K
What is Cellectar Biosciences quarterly retained earnings year-on-year change?
Over the past year, CLRB quarterly retained earnings has changed by -$34.95 M (-16.64%)